EMILY PROPST: Open Payments
NPI 1942667399 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,281 in 67 payments from 14 companies in 2025. Trend: 2023 $37 · 2024 $1,140 · 2025 $1,281
Food & beverage: $1,281
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $571 |
| Janssen Biotech, Inc. | 7 | $208 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $96 |
| PFIZER INC. | 5 | $91 |
| GENZYME CORPORATION | 4 | $79 |
| Gilead Sciences, Inc. | 3 | $61 |
| Celltrion USA Inc. | 2 | $37 |
| Lilly USA, LLC | 1 | $26 |
| Madrigal Pharmaceuticals | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
Products named: RINVOQ, TREMFYA, CREON, DUPIXENT, SKYRIZI, XELJANZ, ENTYVIO, MAVYRET.
Industry payments across NC — which companies pay providers there.
